alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › cognitive-deficits

cognitive-deficits

4 studies tagged cognitive-deficits, dated 2012-01-31 to 2025-03-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits 2025-03-01
  2. Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV 2020-07-17
  3. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model 2014-05-05

Studies

4 studies carry this tag.

Date range

2012 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • European journal of pharmacology 1
  • Journal of neurovirology 1
  • Neurobiology of disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-03-01 Biomarkers

    Blood-based biomarkers may differentiate non-AD-related versus AD-related cognitive deficits.

  2. Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of neurovirology 2020-07-17 Biomarkers

    Our objective was to predict HIV-associated neurocognitive disorder (HAND) in HIV-infected people using plasma neuronal extracellular vesicle (nEV) proteins, clinical data, and machine learning.

  3. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2014-05-05 Biomarkers

    Angiotensin II (AngII) receptor blockers that bind selectively AngII type 1 (AT1) receptors may protect from Alzheimer's disease (AD).

  4. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. European journal of pharmacology 2012-01-31 Biomarkers

    Chronic cerebral hypoperfusion, induced by permanent occlusion of bilateral common carotid arteries (2VO), is related to neurological disorders and contributes to cognitive decline.

All topic tags with their study counts